Open access
Sep 2026
ACT001 suppresses ox-LDL-mediated macrophage ferroptosis via activating the NRF2 pathway: An in vitro mechanistic study relevant to atherosclerosis
Preliminary cell-level evidence of the ACT001 therapeutic potential against macrophage-driven pathological events in atherosclerosis is offered, offering preliminary cell-level evidence of the ACT001 therapeutic potential against macrophage-driven pathological events in atherosclerosis.
Yang-Yang Tao, Yu-Wu Chen, Yong-Hou Zhao et al.
· Experimental and Therapeutic... · 0 citations